vaccines

The race is on not just to develop a coronavirus vaccine, but also determine how to distribute it ethically and efficiently. All Americans likely will have access to a developed vaccine within a year to a year and half of approval, but a CDC advisory group is recommending initial doses go to healthcare workers and high risk groups first.

Prom was canceled because of the pandemic, so Wootton High School’s Class of 2020 decided to donate their unused funds to a local non-profit. News4’s Pat Collins reports.

A Maryland high school donated the money it raised for prom to an effort to fight COVID-19 when the pandemic forced it to cancel the party. Wootton High School’s Class of 2020 collected $1,600 in prom money. “We could have used the money to put in a bench for our school or, I don’t know, planting a tree for our…

With millions of Americans poised to roll up their sleeves for a COVID-19 vaccine, new concerns are growing over those who might inevitably be injured by the shot. There is a multibillion-dollar federal program to cover people injured by vaccines, but the News4 I-Team has learned, at least at first, any new COVID-19 vaccine injuries would not be covered by…

With millions of Americans poised to roll up their sleeves for a COVID-19 vaccine, new concerns are growing over those who might inevitably be injured by the shot. The News4 I-Team’s Jodie Fleischer reports.

Doctors are urging parents to make sure their kids are up to date on their vaccinations, even if they’re doing virtual learning. Health experts say vaccination rates are still not back to pre-pandemic levels, which is needed to prevent a concurrent outbreak during the coronavirus pandemic.

Josh Morrison of 1 Day Sooner is advocating on behalf of volunteers who want to deliberately expose themselves to infections such as COVID-19 to test vaccines and other treatments at great risk to themselves.

As the world awaits an effective Covid-19 vaccine, the New York Times reports on commonly held anti-vax fallacies that provides yet another challenge to eradicating the disease.

A deep dive into the vaccines showing the most promise in battling Covid-19 as volunteer trials get underway.

Moderna’s closely watched early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all 45 participants, the biotech company announced Monday, sending the company’s shares surging more than 26%. Each participant was assigned to receive a 25 microgram, 100 mcg or 250 mcg dose, with 15 people in each dose group. Study participants received two doses of the potential vaccine…

President Donald Trump has suggested multiple times that a coronavirus vaccine could come within months, an accelerated timeline that prominent health experts and veteran vaccine developers say is unlikely absent a miracle. “We’re looking to get it by the end of the year if we can, maybe before,” Trump said Friday during in a Rose Garden event centered on his administration’s efforts...

President Donald Trump announced on Friday that Moncef Slaoui, a former GlaxoSmithKline executive, and Army Gen. Gustave Perna, the commander of United States Army Materiel Command, would lead the new initiative.

Pfizer has begun testing an experimental vaccine to combat the coronavirus in the United States, the pharmaceutical giant announced Tuesday. The U.S.-based company, which is working alongside German drugmaker BioNTech, said the first human participants in the United States have been dosed with the potential vaccine, BNT162. They began human trials of the experimental vaccine late last month in Germany. “With our...

U.S. researchers have opened another safety test of an experimental COVID-19 vaccine, this one using a skin-deep shot instead of the usual deeper jab.

Doctors and researchers hope to deliver a coronavirus vaccine to the American public sometime in the first half of 2021, but new poll findings indicate the bigger public health challenge may be convincing skeptical Americans to obtain a COVID-19 vaccine. A majority of U.S. adults (75%) said in a new LX/Morning Consult poll they’d likely get a coronavirus vaccine,...